-
In this contribution from Germany, Schulz and colleagues provide an annotated, referenced table of therapeutic, toxic, and potentially fatal blood concentrations of nearly 1000 drugs and other xenobiotics (substances foreign to the body that may be ingested or otherwise reach the circulation).
-
Much of the recent attention to the high cost of health care has focused on opposing political viewpoints. Less attention has been given to an equally important issue: How do health care delivery organizations reliably deliver high-value health care and, by doing this, ensure optimal patient outcomes?
-
-
-
Kumar et al set out to describe the cost of ICU telemedicine programs (tele-ICU). They had two objectives: to systematically review the existing literature reporting costs of tele-ICU programs and to provide cost figures for tele-ICU implementation in a Veterans Health Administration (VHA) hospital network.
-
Goldberger and colleagues at the University of Michigan sought to determine the variation in duration of cardiopulmonary resuscitation (CPR) attempts following in-hospital cardiac arrest among different institutions across the United States.
-
In this issue: Side effects of statins; effects of cannabis use; antihypertensives and lip cancer; and FDA actions.
-
In survivors of critical illness with documented cognitive impairment at discharge, commonly used cognitive screening tests do not predict which of these patients will experience long-term cognitive impairment.
-
Investigators of the stroke arrhythmia monitoring Database in Erlangen, Germany, performed continuous telemetric cardiac rhythm monitoring on 501 acute stroke patients admitted to their stroke unit.
-
A history of cancer in a patient with ischemic stroke often raises additional concerns for the clinician, including assessment of cancer activity, as well as possible thrombophilias. The use of thrombolytic agents is also controversial in patients with active cancers.
